Fortrea Holdings Inc. FTRE
Set alert
21.29 USD -1.85 -7.97%
At close · Oct 30
21.49 +0.20 +0.94%
After hours · Oct 30, 5:03 PM ET
20.70 Day range 23.40
8.87 52-week range 25.88
- YTD
- +23.42%
- 1 year
- +112.26%
- Open
- 23.22
- Prev close
- 23.14
- Mkt cap
- 2.05B
- Vol
- 2.87M
- Avg vol
- 1.64M
- EPS
- -0.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.70
- High
- 23.40
- Forward P/E
- 18.35
- Beta
- 0.00
- Short ratio
- 4.32
- Inst. own
- 108.42%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 25, 2027
- 50-d avg
- 20.22
- 200-d avg
- 15.67
- 1y target
- 22.63
2Y chart
Events in this range
- Nov 5, 2025Earnings: 0.12; estimate 0.16; surprise -25%
- Feb 26, 2026Earnings: 0.09; estimate 0.16; surprise -43.75%
- May 5, 2026Earnings: 0.16; estimate 0.03; surprise 433.33%
- Jul 29, 2026Earnings: 0.23; estimate 0.1804; surprise 27.49%
- Oct 6, 2026Rating: Barclays · Equal-Weight → Overweight
- Oct 15, 2026Rating: Deutsche Bank · Hold → Buy
- Oct 20, 2026Rating: UBS · Neutral → Neutral
- Oct 29, 2026Earnings: 0.28; estimate 0.2172; surprise 28.91%
- Oct 30, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Oct 30, 2026Rating: Barclays · Overweight → Overweight
- Oct 30, 2026Rating: Truist Securities · Buy → Buy
Signals (93)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 1 day ago |
| RSI: Overbought | Oct 21, 2026 | 1 week ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 2 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 23, 2026 | 3 months ago |
| RSI: Overbought | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 7, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| RSI: Overbought | Jun 4, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| RSI: Overbought | May 5, 2026 | 5 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| RSI: Oversold | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| RSI: Oversold | Mar 5, 2026 | 8 months ago |
| MACD: Buy Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 18, 2026 | 8 months ago |
| SMA: Bearish | Feb 13, 2026 | 8 months ago |
| RSI: Oversold | Feb 11, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 8 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 30, 2025 | 10 months ago |
| RSI: Overbought | Dec 10, 2025 | 10 months ago |
| RSI: Overbought | Dec 8, 2025 | 10 months ago |
| RSI: Overbought | Dec 3, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 21, 2025 | 11 months ago |
| SMA: Bearish | Nov 19, 2025 | 11 months ago |
| SMA: Bullish | Nov 18, 2025 | 11 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 5, 2025 | 12 months ago |
| MACD: Buy Signal | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 14, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 9, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 17, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| RSI: Overbought | Aug 25, 2025 | 1 year ago |
| RSI: Overbought | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 22, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| SMA: Bearish | Jun 25, 2025 | 1 year ago |
| SMA: Bullish | Jun 24, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 9, 2025 | 1 year ago |
| MACD: Buy Signal | May 29, 2025 | 1 year ago |
| MACD: Sell Signal | May 16, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| RSI: Oversold | Feb 12, 2025 | 1 year ago |
| RSI: Oversold | Feb 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 22, 2025 | 1 year ago |
| RSI: Overbought | Dec 4, 2024 | 1 year ago |
Key statistics
- Market cap
- 2.03B
- Enterprise value
- 3.13B
- Trailing P/E
- 0.00
- Forward P/E
- 18.35
- PEG ratio
- 0.34
- Price / sales
- 0.76
- Price / book
- 3.82
- EPS (TTM)
- -0.91
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -2.58%
- Revenue (TTM)
- 2.67B
- Revenue growth
- -1.40%
- Free cash flow
- 274.39M
- Total cash
- 220.60M
- Total debt
- 1.12B
- Return on equity
- -12.34%
- Shares outstanding
- 96.50M
- Short % of float
- 9.32%
- 50-day average
- 20.22
- 200-day average
- 15.67
Analyst view
Consensus: buy
Buy
Price target (mean) 22.63 +6.3% upside
Now 21.29
- Target (low)
- 13.50
- Target (mean)
- 22.63
- Target (high)
- 27.00
Ratings (0m) 13 7 buy · 4 hold · 2 sell
- Strong buy1
- Buy6
- Hold4
- Sell0
- Strong sell2
Next earnings
Feb 25, 2027
Expected Feb 25, 2027. Consensus EPS estimate 0.21816.
Financials — quick view
FTRE Revenue — quarterly 691.50M
FTRE Net income — quarterly 600.00K
FTRE EPS — quarterly 0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 25, 2027 | Dec 30, 2026 | 0.23 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 0.2172 | 0.28 | +0.06 | +28.91% |
| Jul 29, 2026 | Jun 30, 2026 | 0.1804 | 0.23 | +0.05 | +27.49% |
| May 5, 2026 | Mar 31, 2026 | 0.03 | 0.16 | +0.13 | +433.33% |
| Feb 26, 2026 | Dec 31, 2025 | 0.16 | 0.09 | -0.07 | -43.75% |
| Nov 5, 2025 | Sep 30, 2025 | 0.16 | 0.12 | -0.04 | -25.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Truist Securities | main | Buy | Buy |
| Oct 30, 2026 | Barclays | main | Overweight | Overweight |
| Oct 30, 2026 | Evercore ISI Group | main | Outperform | Outperform |
| Oct 20, 2026 | UBS | main | Neutral | Neutral |
| Oct 15, 2026 | Deutsche Bank | up | Hold | Buy |
| Oct 6, 2026 | Barclays | up | Equal-Weight | Overweight |
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- fortrea.com
News
- Citigroup Maintains Buy on Fortrea Holdings, Raises Price Target to $27
- Truist Securities Maintains Buy on Fortrea Holdings, Raises Price Target to $29
- Barclays Maintains Overweight on Fortrea Holdings, Raises Price Target to $26
- Evercore ISI Group Maintains Outperform on Fortrea Holdings, Raises Price Target to $28
- What Fortrea (FTRE) Said on Its Q3 Earnings Call
- Fortrea Holdings Inc. (FTRE) Q3 2026 Earnings Call Transcript
- Fortrea Holdings Q3 2026 Earnings Call Transcript
- Fortrea Holdings Inc. (FTRE) Q3 Earnings and Revenues Surpass Estimates
- Fortrea Holdings Raises FY2026 Sales Guidance from $2.620B-$2.690B to $2.665B-$2.690B vs $2.663B Est
- Fortrea Holdings Q3 Adj. EPS $0.28 Beats $0.22 Estimate, Sales $691.500M Beat $669.951M Estimate
Your note
Sign in to keep a note on FTRE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MCCONNELL JILL G | Chief Financial Officer | Sale | Jun 1, 2026 | 78,416 |
| MORAIS MARK A | Chief Operating Officer | Sale | Sep 8, 2026 | 86,419 |
| NEUPERT PETER M | Director | Conversion of Exercise of derivative security | May 13, 2026 | 246,668 |
| PESICKA EDWARD A | Director | Conversion of Exercise of derivative security | Jun 9, 2026 | 52,453 |
| PIKE THOMAS | Chief Executive Officer | Sale | Jan 12, 2025 | 159,868 |
| RAY AMRIT | Director | Conversion of Exercise of derivative security | Jun 9, 2026 | 52,453 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.61% | 15,799,104 | 332.89M | Jun 29, 2026 |
| Goldman Sachs Group Inc | 8.85% | 8,414,011 | 177.28M | Jun 29, 2026 |
| Sessa Capital IM, L.P. | 4.83% | 4,593,550 | 96.79M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.40% | 4,181,552 | 88.11M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.01% | 3,816,627 | 80.42M | Jun 29, 2026 |
| State Street Corporation | 3.98% | 3,784,173 | 79.73M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 5,659,969 | 119.26M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 3,000,631 | 63.22M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.63% | 2,497,468 | 52.62M | Sep 29, 2026 |
| Fidelity Capital Trust-Fidelity Value Fund | 2.41% | 2,290,800 | 48.27M | Aug 30, 2026 |
| LOOMIS SAYLES FUNDS II-Loomis Sayles Small Cap Growth Fund | 1.39% | 1,319,079 | 27.79M | Jun 29, 2026 |
| Columbia Acorn Trust-Columbia Acorn Fund | 1.36% | 1,291,989 | 27.22M | Jun 29, 2026 |